To amend the Public Health Service Act to require additional information in State plans for Substance Use Prevention, Treatment, and Recovery Services block grants.
Summary
HB5630 would amend the Public Health Service Act to add new reporting requirements for state plans submitted in connection with Substance Use Prevention, Treatment, and Recovery Services block grants. Specifically, states would have to describe the types of drugs available for medication-assisted treatment, the state’s medication-assisted treatment programs or protocols used to prevent diversion and misuse, data on misuse of medications used in treatment, and data on drug screening protocols used within the state’s system of care.
The bill is focused on increasing transparency and oversight around medication-assisted treatment (MAT) within state substance use treatment systems. It does not appear to change eligibility for block grants or directly mandate treatment practices; instead, it requires states to provide more detailed information about how MAT is administered, monitored, and safeguarded against misuse.
Impact
If enacted, the bill would amend section 1932(b)(1)(A) of the Public Health Service Act and expand the contents of state block grant plans for substance use prevention, treatment, and recovery services. States would need to collect and report additional information on MAT drug availability, diversion-prevention protocols, misuse incidents, and drug screening practices. The practical effect would be to increase federal oversight and data collection requirements for states receiving these block grants, while potentially prompting states to review and formalize their MAT monitoring policies.
Sentiment
There is no recorded committee debate or vote history in the provided materials, so the bill’s sentiment cannot be measured from discussion transcripts or roll calls. Based on the text alone, the measure appears policy-oriented and administrative rather than controversial on its face, with an emphasis on accountability, data reporting, and misuse prevention in substance use treatment programs.
Contention
No specific points of contention are documented in the provided record. Potential areas of debate, however, could include whether the added reporting burden is justified, how broadly states should be required to disclose treatment protocols, and whether increased scrutiny of medication-assisted treatment could improve oversight or inadvertently discourage access to evidence-based care. Any disagreement would likely center on balancing diversion prevention and data collection against state administrative burden and patient access to treatment.
Health: substance use disorder treatment; substance use disorder services programs requirements; modify, and prohibit the promulgation of certain rules. Amends secs. 6230 & 6234 of 1978 PA 368 (MCL 333.6230 & 333.6234).
Expands the purposes of the drug treatment and public education fund to include prevention and recovery programs; requires reporting to be made available on the office of addiction services and supports' website.
Expands the purposes of the drug treatment and public education fund to include prevention and recovery programs; requires reporting to be made available on the office of addiction services and supports' website.
Requires the department of social services to submit a state plan amendment or seek any necessary waivers requesting approval for MO HealthNet coverage of fertility treatments
Increases access to substance use disorder treatment; Requires Medicaid coverage for substance use disorder services provided by community-based organizations.
Increases access to substance use disorder treatment; Requires Medicaid coverage for substance use disorder services provided by community-based organizations.